Columbia Labs (CBRX) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts CBRX Hot Sheet
Join SI Premium – FREE
Columbia Laboratories Inc. (NASDAQ: CBRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $4.76 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
